Vanguard Group Inc Allakos Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Allakos Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,514,345 shares of ALLK stock, worth $4.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,514,345

Previous 3,514,345 -0.0%

Holding current value

$4.22 Million

Previous $3.51 Million 35.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.0 - $1.45 $280,384 - $406,556	-280,384 Reduced 7.39%	3,514,345 $3.51 Million
Q1 2024 May 10, 2024	BUY	$1.02 - $3.23 $549,868 - $1.74 Million	539,087 Added 16.56%	3,794,729 $4.78 Million
Q4 2023 Feb 14, 2024	SELL	$1.72 - $3.18 $17,181 - $31,765	-9,989 Reduced 0.31%	3,255,642 $8.89 Million
Q3 2023 Nov 14, 2023	BUY	$2.13 - $5.55 $36,152 - $94,200	16,973 Added 0.52%	3,265,631 $7.41 Million
Q2 2023 Aug 14, 2023	BUY	$3.6 - $5.25 $1.05 Million - $1.53 Million	291,878 Added 9.87%	3,248,658 $14.2 Million
Q1 2023 May 15, 2023	BUY	$4.3 - $8.27 $18,309 - $35,213	4,258 Added 0.14%	2,956,780 $13.2 Million
Q4 2022 Feb 10, 2023	SELL	$5.66 - $8.42 $905,441 - $1.35 Million	-159,972 Reduced 5.14%	2,952,522 $24.9 Million
Q3 2022 Nov 14, 2022	BUY	$3.02 - $6.12 $4.33 Million - $8.78 Million	1,434,364 Added 85.47%	3,112,494 $19 Million
Q2 2022 Aug 12, 2022	SELL	$2.6 - $6.14 $2.53 Million - $5.99 Million	-974,994 Reduced 36.75%	1,678,130 $5.25 Million
Q1 2022 May 13, 2022	SELL	$5.08 - $9.81 $4.28 Million - $8.26 Million	-841,550 Reduced 24.08%	2,653,124 $15.1 Million
Q4 2021 Feb 14, 2022	BUY	$8.55 - $111.89 $204,481 - $2.68 Million	23,916 Added 0.69%	3,494,674 $34.2 Million
Q3 2021 Nov 12, 2021	BUY	$76.53 - $110.43 $4.08 Million - $5.89 Million	53,313 Added 1.56%	3,470,758 $367 Million
Q2 2021 Aug 13, 2021	BUY	$85.37 - $114.1 $292 Million - $390 Million	3,417,445 New	3,417,445 $292 Million

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $102M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Allakos Inc. Transaction History